The Department of Health manages and implements PBS approved supplier policy to improve the health outcomes of all Australians through access to medicines.
Please visit the Frequently Asked Questions (FAQ) web page for further details about PBS Approved Supplier administrative functions and the PBS Approved Suppliers Portal.
Introduction of application fees in July 2020 for pharmacists seeking approval to supply pharmaceutical benefits
In the 2018-19 Federal Budget, the Australian Government announced that application fees would be introduced for pharmacists seeking approval to supply pharmaceutical benefits. The application fees are to cover the cost of the regulatory activity, which includes work undertaken by both the Department of Health and the Australian Community Pharmacy Authority. The application fees will apply to applications submitted to the Department of Health from 1 July 2020.
As stated in the National Health (Application Fees for Pharmacist Approvals) Determination 2020, the fee amounts are as follows:
- The fee for applications assessed by the Australian Community Pharmacy Authority, will be $5,530. This fee will apply to applications for approval to:
- establish a new pharmacy to supply pharmaceutical benefits, and
- relocate an approved pharmacy (with or without change of ownership).
- The fee for applications assessed by the Department of Health will be $920. This fee will apply to applications for approval to:
- change ownership of an approved pharmacy (not involving relocation), and
- expand or contract the size of an approved pharmacy.
The legislation requires that an application must be accompanied by the application fee; therefore, from 1 July 2020, an applicant’s payer details must be provided when one of the above application types is submitted to the Department of Health.
Applications from medical practitioners and hospital authorities seeking approval to supply pharmaceutical benefits will not incur a fee.
More information can be found on our Frequently Asked Questions webpage. If you have any further questions about the introduction of application fees for pharmacists seeking approval to supply pharmaceutical benefits, please email details of your enquiry to [email protected].
Scheduled Outage of the PBS Approved Suppliers Portal
Commencing 7:30pm Thursday 28 May until 7:30am Friday 29 May 2020 (AEST)
Due to the scheduled outage, the Portal will not be available from 7:30pm Thursday 28 May until 7:30am Friday 29 May 2020 (AEST). The scheduled outage will allow for the following updates to the Portal.
Key changes to PBS Approved Suppliers Portal
- The current Authority for a representative to prepare and submit an application on behalf of the applicant form will be replaced by the Appointment of a representative to prepare and submit an application form. An appointed representative for an application will be prompted to complete and upload the Appointment of a representative to prepare and submit an application form (where applicable) to the Declaration section of the Portal. This form will no longer be required to be attached to the Other Documents section of the PBS Approved Suppliers Portal.
The Applicant(s) Declaration will no longer be required as a separate attachment. This requirement will be replaced with a check box within the Declaration section of the Portal to indicate the declaration has been made.
- If an application has omissions or inconsistencies and is deemed invalid, completion of a new application will no longer be required. The original application will be returned and will appear on the submitter’s dashboard as a draft application for resubmission. The application’s contact nominee will be notified by email on the details of the errors or omissions, and be advised how to resubmit through the PBS Approved Suppliers Portal. The application lodgement date will be the date the application is resubmitted.
Impact of COVID-19 on Approved Pharmacies
The Department of Health is aware of a number of Approved Pharmacies that have closed or changed their business arrangements due to the impact of the COVID-19 pandemic.
It is preferable that pharmacies remain open where possible to ensure that the community has ongoing access to PBS medicines.
However, if an approved pharmacy needs to close due to a COVID-19 related reason and for more than a couple of days, please email [email protected] with:
- the approval number and location
- the reason for closing and intended period of closure
- details of how the community will access medicines during that period.
Please also advise when an approved pharmacy needs to significantly reduce trading hours.
The Department will then work with the individual pharmacies to determine if a formal deactivation of the approval is appropriate.
This information will assist in determining risks to ongoing access to PBS medicines by the community and allow for action to be taken as necessary to mitigate such risks.